EMEA-000026-PIP02-11 - paediatric investigation plan

Temsirolimus
PIPHuman

Key facts

Invented name
  • Torisel
  • Torisel
Active Substance
Temsirolimus
Therapeutic area
Oncology
Decision number
P/262/2011
PIP number
EMEA-000026-PIP02-11
Pharmaceutical form(s)
Concentrate and diluent for solution for infusion
Condition(s) / indication(s)
Treatment of mantle cell lymphoma
Route(s) of administration
Intravenous use
Contact for public enquiries

Pfizer Limited

Tel. + 44 1304646607
E-mail: pip_enquiries@pfizer.com

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date

Decision

Share this page